22 Nov 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Biomedical Research Foundation (BRF) has hired Mr Pradeep K Garg and Ms Sudha Garg to provide the leadership and vision for the newly formed Louisiana Center for Molecular Imaging and Therapy.
Dr Pradeep Garg will be the executive director of the center, which incorporates BRF's PET Imaging Center and Southern Isotopes into a single entity with a mission of advancing the BRF research program. Dr Sudha Garg will be the Center's Director of Radiopharmaceuticals.
Prior to joining BRF, Dr Pradeep Garg was professor of radiological sciences at Wake Forest University School of Medicine, US. Prior to his tenure at Wake Forest, Dr Garg worked at Duke University Medical Center (1987-95) and then moved to a faculty position in the Department of Radiology at the Yale University Medical Center in New Haven (1995-2003) where he later became the director of the Yale University PET Center.
Dr Sudha Garg was an associate professor of Radiology and the associate director of the Ligand Laboratory at the Research PET Center at the Wake Forest University School of Medicine. In this position, she directed the research and production activities relating to the development of novel radiopharmaceuticals. Prior to joining Wake Forest University in 2003, she worked at Molecular Neuroimaging in New Haven, a neuroimaging company specializing in developing novel biomarkers for neuroimaging as the director of radiochemistry.
Dr Pradeep Garg has an academic track record and has published more than 60 peer-reviewed papers and published six book chapters. He has served on numerous committees at his previous institutions and on multiple national and international committees. He is a member of the Society of Nuclear Medicine and Molecular Imaging, Society of Radiopharmaceutical Sciences, Radiological Society of North America, American Chemical Society, and the American Association for Cancer Research and served in leadership positions in many of those organizations.
Over the last several years, BRF has been tracking various emerging sciences and noticed an explosive growth in the field of molecular imaging, a discipline at the intersection of molecular biology and in vivo imaging, thus allowing the visualization of any cellular function and molecular processes. BRF also recognized an ever-growing role of molecular imaging in drug development and translational medical research. The ability to image fine molecular changes offers an incredible number of exciting possibilities for health care including early detection, diagnosis, and even treatment of disease.
BRF envisioned an opportunity to leverage its existing imaging and radiochemistry expertise to establish a Molecular Imaging Center that creates a unique national resource located in Shreveport. According to Dr John George, president and CEO, BRF, "We are very fortunate to have recruited Drs. Pradeep and Sudha Garg to lead the establishment of the Center for Molecular Imaging and Therapy. Their stellar research and clinical resumes, as well as their past success at previous institutions, make this an exciting opportunity for our community, state and region."